New Horizons of Model Informed Drug Development in Rare Diseases Drug Development

Documenti analoghi

• Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
  di: Mariam A. Ahmed, et al.
  Pubblicazione: (2024)
• Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model‐Informed Drug Development Perspective
  di: Rajesh Krishna, et al.
  Pubblicazione: (2025)
• Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases
  di: Susana Neves‐Zaph, et al.
  Pubblicazione: (2024)
• Impact of Model‐Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost
  di: Vaishali Sahasrabudhe, et al.
  Pubblicazione: (2025)
• Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
  di: Jie Chen, et al.
  Pubblicazione: (2025)